"Item","Total","Cards","PCPs","Nephs","Endos","Lipids","HCP","NP/PA","Higher","Lower","Tier 1","Tier 2","Tier 3","Tier 4","Segment A","Segment B","Segment C","Segment D","Priority Account","Non-Priority Account"
"Makes PCSK9s easier to get covered by insurance / get patients on the medication","94 (62.3%)","0 (0%)","26 (52%)","0 (0%)","1 (10%)","1 (10%)","76 (53.1%)","7 (87.5%)","53 (69.7%)","41 (54.7%)","23 (67.6%)","45 (59.2%)","22 (62.9%)","4 (66.7%)","32 (65.3%)","15 (53.6%)","17 (60.7%)","30 (66.7%)","68 (60.7%)","26 (66.7%)"
"Offers an option to patients who can�t or won�t take a statin","85 (56.3%)","0 (0%)","27 (54%)","0 (0%)","1 (10%)","2 (20%)","70 (49%)","6 (75%)","36 (47.4%)","49 (65.3%)","22 (64.7%)","43 (56.6%)","18 (51.4%)","2 (33.3%)","31 (63.3%)","13 (46.4%)","19 (67.9%)","22 (48.9%)","62 (55.4%)","23 (59%)"
"Enables me to use PCSK9s sooner for patients","75 (49.7%)","0 (0%)","20 (40%)","0 (0%)","1 (10%)","1 (10%)","64 (44.8%)","4 (50%)","36 (47.4%)","39 (52%)","16 (47.1%)","38 (50%)","19 (54.3%)","2 (33.3%)","24 (49%)","13 (46.4%)","14 (50%)","23 (51.1%)","59 (52.7%)","16 (41%)"
"Allows me to better customize treatment plans for patients","62 (41.1%)","0 (0%)","23 (46%)","0 (0%)","0 (0%)","0 (0%)","49 (34.3%)","5 (62.5%)","28 (36.8%)","34 (45.3%)","15 (44.1%)","30 (39.5%)","16 (45.7%)","1 (16.7%)","21 (42.9%)","10 (35.7%)","15 (53.6%)","16 (35.6%)","46 (41.1%)","16 (41%)"
"Other (Specify)","1 (0.7%)","0 (0%)","0 (0%)","0 (0%)","1 (10%)","0 (0%)","1 (0.7%)","0 (0%)","0 (0%)","1 (1.3%)","0 (0%)","0 (0%)","1 (2.9%)","0 (0%)","0 (0%)","0 (0%)","0 (0%)","1 (2.2%)","1 (0.9%)","0 (0%)"
